tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market

ArriVent BioPharma, Inc. (AVBP) Technical Analysis

15 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
3Bearish
ArriVent BioPharma, Inc.’s (AVBP) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting ArriVent BioPharma, Inc. is a Sell.
ArriVent BioPharma, Inc.’s (AVBP) 20-Day exponential moving average is 18.13, while ArriVent BioPharma, Inc.’s (AVBP) share price is $18.6, making it a Buy.
ArriVent BioPharma, Inc.’s (AVBP) 50-Day exponential moving average is 18.30, while ArriVent BioPharma, Inc.’s (AVBP) share price is $18.6, making it a Sell.

ArriVent BioPharma, Inc. (AVBP) Pivot Points

Jul 05, 2024, 09:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.31
17.54
17.98
18.21
18.64
18.87
19.31
Fibonacci
17.54
17.80
17.95
18.21
18.46
18.62
18.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ArriVent BioPharma, Inc. (AVBP) Moving Averages

Jul 05, 2024, 09:51 PM
Period
Simple
Exponential
MA5
18.16Buy
18.15Buy
MA10
17.77Buy
18.05Buy
MA20
18.14Buy
18.13Buy
MA50
18.07Buy
18.30Sell
MA100
18.51Sell
18.69Sell
ArriVent BioPharma, Inc.’s (AVBP) 10-Day exponential moving average is 18.05, while ArriVent BioPharma, Inc.’s (AVBP) share price is $18.6, making it a Buy.
ArriVent BioPharma, Inc.’s (AVBP) 100-Day exponential moving average is 18.69, while ArriVent BioPharma, Inc.’s (AVBP) share price is $18.6, making it a Sell.
ArriVent BioPharma, Inc.’s (AVBP) stock price is $18.6 and ArriVent BioPharma, Inc.’s (AVBP) 50-day simple moving average is 18.07, creating a Buy signal.
ArriVent BioPharma, Inc.’s (AVBP) stock price is $18.6 and ArriVent BioPharma, Inc.’s (AVBP) 100-day simple moving average is 18.51, creating a Sell signal.

ArriVent BioPharma, Inc. (AVBP) Technical Indicators

Jul 05, 2024, 09:51 PM
Name
Value
Implied Action
RSI (14)
50.89
Neutral
STOCH (9,6)
75.62
Neutral
STOCHRSI (14)
68.63
Neutral
MACD (12,26)
-0.11
Sell
ADX (14)
23.16
Neutral
Williams %R
-28.27
Buy
CCI (14)
-21.54
Neutral
ATR (14)
1.35
-
Ultimate Oscillator
60.47
Neutral
ROC
-2.09
Sell
ArriVent BioPharma, Inc.’s (AVBP) Relative Strength Index (RSI) is 50.89, creating a Neutral signal.
ArriVent BioPharma, Inc.’s (AVBP) Trend Strength Indicator (ADX) is 23.16, creating a Neutral signal.
ArriVent BioPharma, Inc.’s (AVBP) Commodity Channel Index (CCI) is -21.54, creating a Neutral signal.
ArriVent BioPharma, Inc.’s (AVBP) Price Rate of Change (ROC) is -2.09, creating a Sell signal.

FAQ

Is AVBP a Buy, Hold, or Sell?
Based on AVBP’s technical indicators, AVBP is a Hold.
    What is AVBP’s RSI (14)?
    AVBP’s RSI (14) is 50.89, which suggests AVBP is a Neutral.
      What is AVBP’s MACD?
      AVBP’s MACD is -0.11, which suggests AVBP is a Sell.
        What is AVBP’s 5-day moving average?
        AVBP’s 5-day moving average is 18.16, which suggests AVBP is a Buy.
          What is AVBP’s 20-day moving average?
          AVBP 20-day moving average is 18.14, which suggests AVBP is a Buy.
            What is AVBP’s 50-day moving average?
            AVBP’s 50-day moving average is 18.07, which suggests AVBP is a Buy.
              What is AVBP’s 200-day moving average?
              Currently, no data Available
              What is AVBP’s Williams % R (14)?
              AVBP’s Williams % R (14) is -28.27, which suggests AVBP is a Buy.
                What is AVBP’s CCI (14)?
                AVBP’s CCI (14) is -21.54, which suggests AVBP is a Neutral.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis